The Meals and Drug Administration to start with authorised the injectable medication for managing diabetes in 2017; the agency permitted a drug with an increased dose of the Energetic component in copyright, identified as semaglutide, to deal with weight problems in 2021, under the brand title Wegovy. Since then, converse of the drug has popped up